SHARE:  

Week of April 2, 2024 | Vol. 13, Issue 14

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines



Quick Links

Who We Are

Investment Banking

Strategic Capital

Research


Contact Information

Xan Smith

Managing Director,

Business Development and Sponsor Coverage

xsmith@bourne-partners.com


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

jjohnson@bourne-partners.com

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

Upcoming Events

Events Hosted or Attended by Bourne Partners

ACGGlobal_wAssociationForCorporateGrowth_RGB_1 image
cphi-logo-rgb-na-colour image
MWlogo image
ACGNewYork image

ACG DealMAX 2024

April 29-May 1, 2024 - Las Vegas, NV

CHPI North America 2024

May 7-9, 2024 - Philadelphia, PA

McGuireWoods 20th Annual Healthcare Private Equity and Finance Conference

May 8-9, 2024 - Chicago, IL

2024 ACG New York 16th Annual Healthcare Conference

June 26, 2024 - New York, NY

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

Industry M&A Activity

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

11 transactions totaling $1,281 million


Supplies, Equipment & Services

11 transactions totaling $2,657 million


Healthcare Facilities & Distributors

4 transactions


Healthcare IT & Managed Care

2 transactions

Private Placements

Pharma & Biotech

28 transactions totaling $2,503 million


Supplies, Equipment & Services

19 transactions totaling $259 million


Healthcare Facilities & Distributors

2 transactions totaling $47 million


Healthcare IT & Managed Care

10 transactions totaling $129 million

Public Offerings

Pharma & Biotech

26 transactions totaling $995 million


Supplies, Equipment & Services

7 transactions totaling $63 million


Healthcare Facilities & Distributors

6 transactions totaling $902 million


Healthcare IT & Managed Care

1 transactions totaling $26 million

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

Capital Markets Update: 2024 Outlook

Bourne Partners - Feb 2024

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Bison

Pharma Support Services | Sell-Side 

Acquisition opportunity of a CQV, calibration & metrology, and other pharma support services platform



Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Ignatius

Pharma Services | Sell-Side

Acquisition opportunity of Phase I clinical research site




Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder



Project Panther

Pharma Services | Capital Raise

Investment opportunity in OTC and personal care CDMO


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Matthew Bullard Joins Bourne Partners as a Strategic Advisor

Bourne Partners

AbbVie to Acquire Landos Biopharma

PharmaExec

Key Takeaways from DCAT Week: Simtra BioPharma Solutions

Contract Pharma

Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency

PR Newswire

FUJIFILM Diosynth Biotechnologies Expands Manufacturing Agreement with Argenx for Efgartigimod for the Treatment of Severe Autoimmune Diseases

Fujifilm

Veeda Clinical Research Acquires European CRO, Heads

Contract Pharma

Ingersoll Rand to Acquire ILC Dover to Expand Presence in Life Sciences

Business Wire

With biopharma industry tuned in, Supreme Court hears arguments around medication abortion

Fierce Pharma